Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
|Articles|December 14, 2015
A 5-Question Quiz on Infectious Disease
This quick quiz focuses on testing and diagnosis. Test your acumen.
Advertisement
Question 1:
Answer and new question on next page »
The correct answer is E. HBsAg
For a discussion of the case,
Question 2:
Answer and new question on next page »
The correct answer is D. Anti-VCA IgM
For a discussion of the case,
Question 3:
Answer and new question on next page »
The correct answer is A. True
For a discussion of the case,
Question 4:
Answer and new question on next page »
The correct answer is C. Staphylococcus aureus
For a discussion of the case,
Question 5:
Answer on next page »
The correct answer is B. Hepatitis B virus
For a discussion of the case,
Advertisement
Related to this article
FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Grants Breakthrough Device Designation to Natera's Multi-Cancer Early Detection Blood Test
2
Who Should Get a CGM? Expanding the Primary Care Candidate Pool
3
Most Adolescents With Colorectal Cancer Diagnosed at Advanced Stage, Study Finds
4
PrEP Deserts: Why HIV Prevention Still Misses Those at Risk
5